Edenred SE

ENXTPA:EDEN Rapport sur les actions

Capitalisation boursière : €6.1b

Edenred Croissance future

Future contrôle des critères 2/6

Edenred devrait augmenter ses bénéfices et ses revenus de 8.4% et de 6.6% par an respectivement, tandis que le BPA devrait croître de croître de 7.8% par an.

Informations clés

8.4%

Taux de croissance des bénéfices

7.80%

Taux de croissance du BPA

Diversified Financial croissance des bénéfices45.6%
Taux de croissance des recettes6.6%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Good

Dernière mise à jour27 Jul 2026

Mises à jour récentes de la croissance future

Recent updates

Mise à jour du récit • Jul 03

EDEN: High Debt And Macro Headwinds Will Restrain Benefit From Buyout Interest

Analysts have nudged the Edenred fair value estimate higher from €17.70 to €19.00, reflecting updated price targets that factor in tighter cost control, fuel related tailwinds and stronger float revenues, while still keeping an eye on macro risks, competition and leverage. Analyst Commentary Recent price target revisions for Edenred point to a more measured stance from some research desks, with the focus shifting toward how well the company can execute on cost control and manage balance sheet risks while operating under macro pressure.
Mise à jour du récit • Jun 19

EDEN: Future Upside Will Rely On Cost Control And Float Income

The analyst price target for Edenred has been nudged higher to €27.53 from €27.01. This reflects updated views that incorporate a slightly different discount rate, modestly adjusted growth and margin assumptions, and recent Street research pointing to mixed but incrementally more supportive commentary on cost control, fuel tailwinds, and float revenues.
Mise à jour du récit • Jun 04

EDEN: Future Upside Will Depend On Discount Rate And P E Climate

Analysts raised their price targets for Edenred, increasing them by several euros per share. The changes reflect updated assumptions on discount rates, revenue growth and long-term P/E multiples, while views on profit margins remained broadly unchanged.
Mise à jour du récit • May 02

EDEN: Future Upside Will Rely On Discount Rate And P E Normalization

Edenred's updated analyst price target edges higher to about €27.01 from €26.41, reflecting analysts' refined assumptions on the discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Recent Street research on Edenred offers a mix of optimism and caution, with several price target changes in both directions over a relatively short period.
Mise à jour du récit • Apr 18

EDEN: Future Upside Will Rely On Reset Expectations And P/E Multiple Normalization

Edenred's updated analyst price target has slipped slightly to €26.41 from €26.85, reflecting more measured assumptions for revenue growth, profit margins and discount rates, while still applying a modestly higher future P/E multiple. Analyst Commentary Recent Street research on Edenred presents a mix of optimism and caution, with several firms adjusting price targets in both directions and one downgrade.
Mise à jour du récit • Apr 03

EDEN: Rebased Earnings Assumptions Will Support Upside Despite Recent P/E Reset

Edenred's analyst price target has been revised to €37.00 from €42.00, as analysts factor in updated assumptions for revenue growth, profit margins, discount rates and future P/E following a series of recent target cuts and a downgrade from major banks. Analyst Commentary Recent Street research on Edenred has centered on recalibrated targets rather than fresh upgrades, but the tone of several reports still highlights areas that bullish analysts view as supportive for the current valuation and long term growth potential.
Mise à jour du récit • Mar 20

EDEN: Cautious UBS Downgrade And Index Inclusion Will Shape Risk Balance

Analysts have trimmed their price target on Edenred to €17.70, citing slightly lower assumed revenue growth and profit margins, partly offset by a reduced discount rate and a modestly higher future P/E multiple. Analyst Commentary Recent research points to a more cautious tone around Edenred, with the latest price target revision to €17.70 reflecting a reassessment of the balance between growth potential and execution risks.
Mise à jour du récit • Mar 05

EDEN: Future Upside Will Depend On Repriced P/E Multiple Normalization

Narrative Update The updated analyst price target for Edenred has moved from about €32.55 to roughly €26.85, as analysts factor in a lower assumed future P/E multiple despite steady assumptions on growth, margins, and discount rate following the recent downgrade. Analyst Commentary Analysts are reassessing Edenred after the recent downgrade, mainly by rethinking how much they are willing to pay for the company through a lower assumed future P/E multiple, rather than changing their view on the underlying growth and margins.
Mise à jour du récit • Feb 19

EDEN: UBS Downgrade And Index Shift Will Frame Buyback Outlook

Narrative Update on Edenred Analysts have trimmed their Edenred price target by €0.00 to €17.70, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E that together point to a marginally different risk and earnings profile. Analyst Commentary Bearish analysts are signaling a more cautious stance on Edenred, with the latest trim in the price target to €17.70 framed as a reflection of adjusted assumptions rather than a major change in the investment case.
Mise à jour du récit • Feb 05

EDEN: Index Changes And UBS Downgrade Will Frame Buyback And Charging Plans

Analysts have trimmed their price target on Edenred to €17.70. This reflects updated assumptions around the discount rate, revenue growth, profit margins and future P/E multiples following recent research, including a downgrade at UBS.
Mise à jour du récit • Jan 22

EDEN: Index Shift And Buyback Plans Will Balance Charging Network Expansion

Narrative Update Analysts have nudged their Edenred target slightly higher to €17.70, reflecting small adjustments to discount rate, revenue growth, profit margin assumptions and a modestly lower future P/E multiple in their models. What's in the News Edenred SE is set to be added to the CAC Next20 Index, signaling that it will be included in this French equity benchmark (Index Constituent Adds).
Mise à jour du récit • Jan 08

EDEN: Cautious Outlook Will Balance Index Inclusion And Partnership Expansion

Narrative update on Edenred The analyst price target for Edenred has been revised down from €27.0 to €17.7, as analysts adjust their views on fair value, discount rate, revenue growth, profit margins and future P/E in line with recent Street target cuts to €28 and €43 from different banks. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Edenred, with price targets now clustered in a lower range between €28 and €43.
Mise à jour du récit • Dec 23

EDEN: Index Inclusion Will Support Upside Despite Recent Price Objective Cuts

Analysts have trimmed their price target on Edenred, cutting fair value from EUR 49.00 to EUR 42.00 as they factor in slightly slower revenue growth, modestly lower profit margins, and a higher discount rate in line with recent Street target reductions. Analyst Commentary Recent Street updates reflect a more measured but still constructive stance on Edenred, with price targets adjusted to reflect macro uncertainty and sector-wide de-rating rather than company specific execution issues.
Mise à jour du récit • Dec 09

EDEN: Future Upside Will Depend On Resolution Of French Taxation Risk

Analysts have trimmed their price target on Edenred to about EUR 32.55 from roughly EUR 33.62. This reflects slightly lower assumptions for revenue growth, profitability, and valuation multiples following recent sector wide target cuts and a more cautious stance on potential changes to employee benefit taxation in France.
Mise à jour du récit • Nov 25

EDEN: Future Upside Will Depend On Successful Resolution Of Regulatory Risks

The analyst price target for Edenred has been reduced from €34.85 to €33.62. This change reflects a more cautious outlook from analysts amid concerns about softer revenue growth, profit margins, and ongoing regulatory uncertainties.
Article d’analyse • Nov 21

The Market Doesn't Like What It Sees From Edenred SE's (EPA:EDEN) Earnings Yet As Shares Tumble 28%

The Edenred SE ( EPA:EDEN ) share price has fared very poorly over the last month, falling by a substantial 28...
Mise à jour du récit • Nov 08

EDEN: Future Gains Will Depend On Successful Rollout Of Visa Partnership

The analyst price target for Edenred has been revised downward. Recent updates indicate a shift from approximately €35.28 to €34.85 per share, as analysts cite concerns over regulatory risks and moderated growth expectations.
Mise à jour du récit • Oct 25

Regulatory Headwinds And New Partnerships Will Shape Market Opportunities Ahead

Edenred's analyst price target has been revised downward from €30.82 to €35.28. This change reflects recent analyst caution following lowered price targets and a shift in ratings due to concerns over regulatory changes in France.
Mise à jour du récit • Oct 11

Digital Payments And Untapped Markets Will Unlock Potential

Analysts have lowered their fair value estimate for Edenred from €36.88 to €35.82. This adjustment reflects increased caution following recent sector downgrades and concerns about potential regulatory headwinds in France.
Mise à jour du récit • Sep 27

Digital Payments And Untapped Markets Will Unlock Potential

Edenred's consensus price target has been revised downward to €36.88 as analysts weigh increased regulatory risks and macroeconomic uncertainty, with cautious optimism around cost control and operational resilience offset by concerns over potential taxation of employee benefits in France. Analyst Commentary Bearish analysts cited increased risk from potential taxation of employee benefits in France, reducing confidence in Edenred's growth outlook.
Mise à jour du récit • Sep 12

Digital Payments And Untapped Markets Will Unlock Potential

Edenred’s consensus price target was slightly reduced to €39.10 as analysts anticipate Italian market headwinds and a lack of near-term catalysts despite solid cost control and ongoing long-term confidence from major firms. Analyst Commentary Bearish analysts lowered price targets primarily due to expected upcoming headwinds in the Italian market.
User avatar
Nouveau récit • Nov 28

Dynamic Market Expansion Will Boost Revenue Growth Despite European Challenges

Expansion in underpenetrated markets and strategic acquisitions are consolidating Edenred's market position and boosting revenue and net margins.

Prévisions de croissance des bénéfices et des revenus

ENXTPA:EDEN - Estimations futures des analystes et données financières antérieures (EUR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20283,3715769531,05313
12/31/20273,1565138791,02714
12/31/20262,96144847685112
6/30/20262,7545001,0511,254N/A
3/31/20262,7435111,0621,262N/A
12/31/20252,7325211,0721,270N/A
9/30/20252,8175148651,071N/A
6/30/20252,789507658872N/A
3/31/20252,699507735951N/A
12/31/20242,6095078121,029N/A
9/30/20242,5554048491,061N/A
6/30/20242,5013008851,093N/A
3/31/20242,4062848741,073N/A
12/31/20232,3112678621,052N/A
9/30/20232,2233438491,026N/A
6/30/20232,134418835999N/A
3/31/20232,0394028491,006N/A
12/31/20221,9443868621,013N/A
9/30/20221,841368807950N/A
6/30/20221,738350752886N/A
3/31/20221,661332621745N/A
12/31/20211,583313490604N/A
9/30/20211,534292380485N/A
6/30/20211,484271269366N/A
3/31/20211,454255442542N/A
12/31/20201,423238614718N/A
9/30/20201,460252558670N/A
6/30/20201,497266502621N/A
3/31/20201,534289N/A543N/A
12/31/20191,570312N/A465N/A
9/30/20191,503294N/A538N/A
6/30/20191,435276N/A611N/A
3/31/20191,381265N/A569N/A
12/31/20181,327254N/A526N/A
9/30/20181,302248N/A543N/A
6/30/20181,277242N/A559N/A
3/31/20181,265242N/A527N/A
12/31/20171,253241N/A494N/A
9/30/20171,224237N/A435N/A
6/30/20171,195232N/A375N/A
3/31/20171,134206N/A394N/A
12/31/20161,073180N/A413N/A
9/30/20161,032173N/A363N/A
6/30/2016991166N/A312N/A
3/31/2016996172N/A325N/A
12/31/20151,000177N/A337N/A
9/30/20151,006177N/A332N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de EDEN ( 8.4% par an) est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Les bénéfices de EDEN ( 8.4% par an) devraient croître plus lentement que le marché French ( 12.2% par an).

Croissance élevée des bénéfices: Les bénéfices de EDEN devraient augmenter, mais pas de manière significative.

Chiffre d'affaires vs marché: Le chiffre d'affaires de EDEN ( 6.6% par an) devrait croître plus rapidement que le marché French ( 5.6% par an).

Croissance élevée des revenus: Le chiffre d'affaires de EDEN ( 6.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de EDEN devrait être élevé dans 3 ans

Découvrir les entreprises en croissance

7D

1Y

7D

1Y

7D

1Y

Analyse de l'entreprise et données financières

DonnéesDernière mise à jour (heure UTC)
Analyse de l'entreprise2026/07/27 04:47
Cours de l'action en fin de journée2026/07/24 00:00
Les revenus2026/06/30
Revenus annuels2025/12/31

Sources de données

Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.

PaquetDonnéesCadre temporelExemple de source américaine *
Finances de l'entreprise10 ans
  • Compte de résultat
  • Tableau des flux de trésorerie
  • Bilan
Estimations consensuelles des analystes+3 ans
  • Prévisions financières
  • Objectifs de prix des analystes
Prix du marché30 ans
  • Cours des actions
  • Dividendes, scissions et actions
Propriété10 ans
  • Actionnaires principaux
  • Délits d'initiés
Gestion10 ans
  • L'équipe dirigeante
  • Conseil d'administration
Principaux développements10 ans
  • Annonces de l'entreprise

* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.

Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.

Modèle d'analyse et flocon de neige

Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.

Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.

Indicateurs de l'industrie et du secteur

Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.

Sources des analystes

Edenred SE est couverte par 26 analystes. 14 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.

AnalysteInstitution
Pravin GondhaleBarclays
Edward BirkinBarclays
Julian EasthopeBarclays